Mark Allen O’Rourke

8.1k citations

82 papers · 5.7k indexed · 3 hit papers · h-index 26

Impact in

Oncology top 0.5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in

Oncology 43
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 9
- Lung Cancer Research Studies 7
- Cancer survivorship and care 6
Research and Theory 1

Co-authors: Brian G. Spratt John Maynard Smith N. H. Smith J. Bérille Susan Coughlin Yong Kim Nathan Levitan Ronald L. Burkes
Journals: Journal of Clinical Oncology (31 papers)Investigational New Drugs (4 papers)JCO Oncology Practice (3 papers)Cancer Investigation (3 papers)The Oncologist (3 papers)
Partner nations: United States Israel United Kingdom

In The Last Decade

Mark Allen O’Rourke

75 papers receiving 5.5k citations

Hit Papers

align trajectories log scale

Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500 2014 · 482 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Journal of Clinical Oncology
2000 Journal of Clinical Oncology
1993 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Mark Allen O’Rourke

Since Specialization

Citations

This map shows the geographic impact of Mark Allen O’Rourke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Allen O’Rourke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Allen O’Rourke more than expected).

Fields of papers citing papers by Mark Allen O’Rourke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Allen O’Rourke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Allen O’Rourke. The network helps show where Mark Allen O’Rourke may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Allen O’Rourke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Allen O’Rourke Line = papers co-authored together Mark Allen O’Rourke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer Cancer ·Virginia Sun, Katherine A. Guthrie, Tracy E. Crane, Kathryn B. Arnold, М Н Киселев, S Kassin, YK Yee, Kazufuyu Sudoh, Craig Messick, Joseph C. Carmichael, Mardônio V. Queiroz, Kathy Lowler, Madhuri Bajaj, Stacey A. Cohen, Devin C. Flaherty, Mark Allen O’Rourke, Lee Jones, Robert S. Krouse, Cynthia A. Thomson	2024	0
2	Feasibility and acceptability of an online intervention to enhance hopefulness among oncology professionals JNCI Cancer Spectrum ·Benjamin W. Corn, David B. Feldman, Ishwaria M. Subbiah, Feng Dong-ling, Marie Bakitas, Robert S. Krouse, Ângela Maria Israel, 石丽婷, علیرضا ایزدفر, Walter Weizel, Rajiv Agarwal, 保之柴田, Jyotsana Parajuli, Jamie Myers, Mark Allen O’Rourke	2023	5
3	Modifiable fall risk factors among older adults with advanced cancer: Secondary analysis of a cluster-randomized clinical trial Journal of Geriatric Oncology ·B. Ravi Kiran Patnaik, 庸子三浦, Kah Poh Loh, Megan Wells, L. I. Panina, Erika Ramsdale, Beverly Canin, Jodi Geer, Mark Allen O’Rourke, Jane Jijun Liu, Christopher L. Seplaki, Supriya G. Mohile, Tanya M. Wildes	2023	1
4	Hope, Burnout, and Life Satisfaction: An Intriguing Trinity Among Investigators of the SWOG Cancer Research Network JCO Oncology Practice ·David B. Feldman, Mark Allen O’Rourke, Marie Bakitas, Robert S. Krouse, Mohanna Khandan, Ângela Maria Israel, Benjamin W. Corn	2021	8
5	Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials JCO Oncology Practice ·Cherif Samiha Samiha, Amy K. Darke, Katherine A. Guthrie, Jeff A. Sloan, Joseph M. Unger, Dawn L. Hershman, Mark Allen O’Rourke, Marie Bakitas, Robert S. Krouse	2021	14
6	S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients JNCI Journal of the National Cancer Institute ·Veena Shankaran, Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas, Sreenivasa R Chandana, Mark Allen O’Rourke, Taylor Vincent, Jovana Vukajlovic, Dawn L. Hershman, Scott D. Ramsey	2021	39
7	Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials JCO Oncology Practice ·David Hui, Amy K. Darke, Katherine A. Guthrie, Ishwaria M. Subbiah, Joseph M. Unger, Dawn L. Hershman, Robert S. Krouse, Marie Bakitas, Mark Allen O’Rourke	2021	5
8	Multilevel predictors of guideline concordant needle biopsy use for non-metastatic breast cancer Breast Cancer Research and Treatment ·Anja Zgodic, Jan M. Eberth, Benjamin D. Smith, Whitney E. Zahnd, Swann Arp Adams, Brian McKinley, Ronnie D. Horner, Mark Allen O’Rourke, Dawn W. Blackhurst, Matthew F. Hudson	2021	1
9	Symptom Management Among Cancer Survivors: Randomized Pilot Intervention Trial of Heart Rate Variability Biofeedback Applied Psychophysiology and Biofeedback ·James B. Burch, J. P. Ginsberg, Alexander C. McLain, Jiwoon Shin, Sherry Stokes, Gregor Schorberger, Gathot Winarso, Elizabeth Crowley, 장경순, Ronald John Grill, Ankita Bora, James R. Hébert, Mark Allen O’Rourke	2020	29
10	Using immersive 3D computer games to help engage learners and deliver skill sets RMIT Research Repository (RMIT University Library) ·Mark Allen O’Rourke	2013	1
11	Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer Clinical Colorectal Cancer ·Leonard B. Saltz, Suprith Badarinath, Shaker R. Dakhil, Gladys G. Handy, W G Harker, J.C. Farine, Cristian Ordoñez-Avila, Jiabei Hou, Paul Conkling, Mark Allen O’Rourke, Donald Richards, Diane Reidy‐Lagunes, David B. Solit, Efsevia Vakiani, Sam Kestenbaum, Katherine J. Hensel, Zhan Feng, Kristi A. Boehm, Lina Asmar, Allen Lee Cohn	2011	58
12	A Phase I Study of the Chinese Herbal Medicine PHY906 as a Modulator of Irinotecan-based Chemotherapy in Patients with Advanced Colorectal Cancer Clinical Colorectal Cancer ·Shivaani Kummar, Mehmet Sitki Copur, Michal G. Rose, Scott Wadler, Joe Stephenson, Mark Allen O’Rourke, Wayne D. Brenckman, Robert D. Tilton, Shwu-Huey Liu, Zaoli Jiang, Robert T. Singkoh, Yung-Chi Cheng, Edward Chu	2011	89
13	Playing your way to competency Victoria University Research Repository (Victoria University) ·Mark Allen O’Rourke, Hugo Audouin	2009	2
14	Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy Journal of Clinical Oncology ·Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson, Richard J. Gralla, Mark Allen O’Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald L. Burkes, Susan Coughlin, Yong Kim, J. Bérille Hit paper breakdown →	2000	1717
15	Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer Gynecologic Oncology ·Robert A. Burger, Philip J. DiSaia, 满学先, Mark Allen O’Rourke, David M. Gershenson, Howard D. Homesley, Stuart M. Lichtman, Willard A. Barnes, David H. Moore, Bradley J. Monk	1999	53
16	Phase II Evaluation of Ifosfamide/Mesna in Metastatic Prostate Cancer American Journal of Clinical Oncology ·Stephen K. Williamson, Michael Wolf, Mario A. Eisenberger, Mark Allen O’Rourke, William Brannon, E. David Crawford	1996	6
17	Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer Investigational New Drugs ·Stephen K. Williamson, Michael Wolf, Mario A. Eisenberger, Mark Allen O’Rourke, William Brannon, E. David Crawford	1995	21
18	Further evidence for the non-clonal population structure of Neisseria gonorrhoeae: extensive genetic diversity within isolates of the same electrophoretic type Microbiology ·Mark Allen O’Rourke, Brian G. Spratt	1994	46
19	High-Dose 24-Hour Infusion of 5-Fluorouracil in Metastatic Prostate Cancer American Journal of Clinical Oncology ·James N. Atkins, Hyman B. Muss, Douglas Case, Joni K. Brockschmidt, Frederick M. Schnell, Mark Allen O’Rourke, Thomas Grote, 琳乔, Susan Anthony, Issac Fradkin	1991	23
20	Unilateral Pseudo-Synophthalmos Journal of Pediatric Ophthalmology & Strabismus ·Mark Allen O’Rourke, S. Lance Forstot, Philip P. Ellis	1989	1

About Mark Allen O’Rourke

Mark Allen O’Rourke is a scholar working on Oncology, Research and Theory, Applied Psychology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology, having authored 82 papers that have together received 5.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Lung Cancer Treatments and Mutations (13 papers), Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Palliative Care and End-of-Life Issues (6 papers), Cancer survivorship and care (6 papers) and Economic and Financial Impacts of Cancer (5 papers). The work is most often cited by research in Oncology (3.1k citations), Pulmonary and Respiratory Medicine (2.3k citations), Cancer Research (754 citations), Microbiology (282 citations) and Endocrinology (194 citations). Mark Allen O’Rourke has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Brian G. Spratt, John Maynard Smith, N. H. Smith, J. Bérille, Susan Coughlin, Yong Kim, Nathan Levitan, Ronald L. Burkes, Janet Dancey and Richard J. Gralla. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, JCO Oncology Practice, Cancer Investigation and The Oncologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact